amphetamine has been researched along with Fatty Liver in 2 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dercum disease is a rare disorder of painful subcutaneous adipose tissue masses typically presenting as a constellation of signs and symptoms affecting most organs, including slow lymphatic flow and fatty liver." | 1.48 | Low-Dose d-Amphetamine Induced Regression of Liver Fat Deposits in Dercum Disease. ( Bilal, J; Ghazala, S; Herbst, KL; Kalb, B; Riaz, IB; Ross, E, 2018) |
| " Pathohistology revealed microvascular steatosis in the liver, which raised the possibility of chronic use of toxic substances." | 1.38 | [A new designer drug: methylone related death]. ( Kereszty, EM; Kovács, K; Tóth, AR, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghazala, S | 1 |
| Bilal, J | 1 |
| Ross, E | 1 |
| Riaz, IB | 1 |
| Kalb, B | 1 |
| Herbst, KL | 1 |
| Kovács, K | 1 |
| Tóth, AR | 1 |
| Kereszty, EM | 1 |
2 other studies available for amphetamine and Fatty Liver
| Article | Year |
|---|---|
Low-Dose d-Amphetamine Induced Regression of Liver Fat Deposits in Dercum Disease.
Topics: Adiposis Dolorosa; Amphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatt | 2018 |
[A new designer drug: methylone related death].
Topics: Adolescent; Amphetamine; Asthma; Autopsy; Causality; Death, Sudden, Cardiac; Designer Drugs; Drug Ov | 2012 |